Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. - Wikidata - awgldk - TriplyDB

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

http://www.wikidata.org/entity/Q34332698

about

Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins Analysis of human immunodeficiency virus type 1 Gag ubiquitination Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.Retroviruses have differing requirements for proteasome function in the budding process Role of ESCRT-I in retroviral budding Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients Ubiquitin Depletion and Dominant-Negative VPS4 Inhibit Rhabdovirus Budding without Affecting Alphavirus Budding Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect.Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2 A cell-penetrating helical peptide as a potential HIV-1 inhibitor.Defects in cellular sorting and retroviral assembly induced by GGA overexpression Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus.Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.Equine infectious anemia virus and the ubiquitin-proteasome system.Viral late domains YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42 Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.Identification of conserved motifs in the West Nile virus envelope essential for particle secretion Potential roles of cellular proteins in HIV-1.Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release.Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release.Exosome secretion: the art of reutilizing nonrecycled proteins?The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy.HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway.Molecular characterization of feline immunodeficiency virus budding.PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected].Late domain-dependent inhibition of equine infectious anemia virus budding The YPLGVG sequence of the Nipah virus matrix protein is required for budding Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding.Functional replacement of a retroviral late domain by ubiquitin fusion.Lysines close to the Rous sarcoma virus late domain critical for budding.How ubiquitin functions with ESCRTs Application of a split luciferase complementation assay for the detection of viral protein-protein interactions The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles.Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies.Context-dependent effects of L domains and ubiquitination on viral budding.A Truncated Nef Peptide from SIVcpz Inhibits the Production of HIV-1 Infectious Progeny.

P2860

Q24296475-50B68EEB-E757-4C8C-B918-8C8AA3E854A7 Q24531968-7D6A5F26-C24F-4B70-B0A5-1380AC5A32A2 Q24541306-BE06728E-219B-4FD8-8A51-DA0B5160C4D4 Q24550599-30999555-7047-47D5-9616-84ED25D62C6D Q24554467-C95B15B2-47F1-419F-9E6F-C023A7D6F85B Q24682537-D803B7D7-4690-427F-A8F0-611FA2973DEE Q27482207-EA731471-AFC2-4D75-9C72-052450B5F749 Q27485001-53BDCC05-E7D6-4244-9991-A49E5B070D9D Q27863926-BACD3450-9BC3-4251-85C6-85EAE7CB02EA Q30482790-B180FE46-3BAC-4130-BB1B-1673CD474632 Q33326188-45DA8665-712E-4BD7-A172-231E8642F5B1 Q33507450-98469B1D-6892-474C-8847-6896A4ABB595 Q33835398-A07E2593-DD54-46C8-A31A-C089481211D2 Q33884090-FD927AB0-A5FF-4BDF-B5EC-F9AF9B890E77 Q34332683-50BD005A-B2AB-4DBD-AD86-7A09FB5CCF6C Q34338672-07F9A8D0-7590-4103-8056-7950769A8870 Q34493909-5F81620F-39C1-47E6-B99A-FA556285E9F3 Q34593906-CEE9C6DC-7904-4876-ACEE-149595E524C7 Q34978989-F3503379-D4C4-46DF-90C1-C741A714ADAE Q34985857-BEE05442-0924-4D8D-BEB5-E2D122B904B5 Q34989840-6FED3A97-86BC-45DA-BA7B-E3C05774017A Q35313971-42501F56-9847-4CA1-A2CD-0A15E9561432 Q35542714-88CED33D-AA71-4D0D-8379-3112CBAC2793 Q35915775-9562541D-2719-447D-811A-0FE02D50F334 Q36066214-D4B7AE73-341E-45BE-9E24-107B3880E124 Q36321265-1775D53E-AFCB-4AD3-905F-B74C67A57BE0 Q36483903-974C06D2-0DD3-421C-BEBA-4F82F7545748 Q36879741-16F06BCE-8A9D-43AA-9E06-9E1A4509764A Q36944434-6A8464F1-3AB7-4BF1-A9A2-32EC6ECADBF2 Q37059301-8DC15EF2-AC64-4A53-8AFD-01905E4204B9 Q37116827-521A8584-76FA-4749-86AC-368D875F99A1 Q37390982-0D391F41-BB83-4281-9501-6CDFCA4DB403 Q37511457-8038881D-38E9-4F5E-BC4E-561B3FF092FF Q37896711-5C64A55E-92F6-478C-BEB4-4A71499C2F10 Q39529869-683D17BE-F10C-401A-A9F4-3BDC8516C8A2 Q39735600-1AAF8C9E-1EC7-44FE-84D6-8DDA104416C0 Q40096523-A9F9DFAB-42D0-4A2E-B94D-FFF2D355A938 Q40096537-73FC3E2E-2D3E-4A88-84CE-CB74645E151A Q40533990-515C251D-C296-496F-898A-69E8BB18EF4F Q40618525-46B6D9B3-D099-417A-BC8F-EB7CB136FFD1

P2860

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

http://www.wikidata.org/entity/Q34332698

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@ast

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@en

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@nl

type

label

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@ast

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@en

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@nl

prefLabel

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@ast

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@en

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@nl

P1433

Q34332698-1130558D-15DA-430E-981A-BC162CEA53CE

P1476

Q34332698-971D5A1C-5843-4CF0-BB65-1442D8FB12C4

P2093

Q34332698-1D52D2FA-9543-4751-AD92-5074BAE3A137

Q34332698-5AC39425-1050-473D-9B9E-03E67B5AE531

Q34332698-7457BCE9-0076-4E61-AB0E-45B97FADA816

Q34332698-AE32737D-AEDD-4CFC-AA4B-D7184BD2ADFF

Q34332698-E3DA0084-2BCD-4D91-8151-3DDAB50737F7

P2860

Q34332698-0459CA03-6A90-44FA-AB63-D28250264F72

Q34332698-0A179AF9-1E92-4718-87B4-6FB5456B1827

Q34332698-19D894C0-F2BD-4BA0-8763-B42A1DEBAC54

Q34332698-2274C2E9-CC35-4449-910B-9A9ED61D9581

Q34332698-3F4497EA-B35A-4849-B4A5-68F824369296

Q34332698-53B77CE0-8214-4411-BDAB-5A13EAC37017

Q34332698-5A5531B3-C862-41DA-A489-597DCC04F4E3

Q34332698-6491447E-85C0-408C-A70A-F1A76940979F

Q34332698-656E3D78-6BA8-4116-ADD5-724F438842F0

Q34332698-6C5C4592-7704-4161-BDE7-3531D1B467DF

P304

Q34332698-5CC1E1EF-C7FB-42D4-8FB1-9DDC8691BB8E

P31

Q34332698-F19C08CE-00A3-4C2E-B57B-5D584B1B9116

P356

Q34332698-147EE9EF-D38C-4415-B727-AD38E1F505A5

P407

Q34332698-F3000525-0D11-4074-9F8C-B8871A62459D

P433

Q34332698-0AA3FBEF-3796-4FA7-B65C-9DFE3F24E95C

P478

Q34332698-350F16C8-344E-49E9-85DA-C9E2AE2E33CA

P577

Q34332698-D015F9EE-8F84-4F5D-A66E-26E97BAE529E

P698

Q34332698-93732143-BAB1-4347-80A9-C88E30D9B3AA

P932

Q34332698-AF4AE311-E59F-4D37-A8ED-283B1327D074

P356

JVI.76.6.2641-2647.2002

P1433

Journal of Virology

P1476

Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

@en

P2093

Akash Patnaik

http://www.w3.org/2001/XMLSchema#string

Feng Li

http://www.w3.org/2001/XMLSchema#string

John W Wills

http://www.w3.org/2001/XMLSchema#string

Ronald C Montelaro

http://www.w3.org/2001/XMLSchema#string

Vincent Chau

http://www.w3.org/2001/XMLSchema#string

P2860

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus

Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)

A role for ubiquitin ligase recruitment in retrovirus release

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

An assembly domain of the Rous sarcoma virus Gag protein required late in budding

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

Protein regulation by monoubiquitin

Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain

P304

2641-2647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.6.2641-2647.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11861830

http://www.w3.org/2001/XMLSchema#string

P932

135976

http://www.w3.org/2001/XMLSchema#string